Science Explorer Back to mapMap
Discussion
Researcher · Asklepios Klinikum Harburg · Germany

Claas Wesseler

Claas Wesseler publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging, on topics such as Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Lung Cancer Research Studies.

ORCID 0000-0002-9261-7504 OpenAlex
World rank
#2,346,224
of 7,710,434 ranked researchers
Rank in Germany
#115,931
of 364,343
Works
66
Citations
800
Citations per work
12.1
h-index
13
i10-index 17Top 38% in Pulmonary and Respiratory Medicine
Claas Wesseler

What does Claas Wesseler research?

Claas Wesseler's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (6%).

Health Sciences: 52 works · 78.7% of their workMedicine: 52 works · 78.7% of their workPulmonary and Respiratory Medicine: 27 works · 40.2% of their workOncology: 21 works · 31.5% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 4.3% of their workNeurology: 2 works · 2.7% of their workEverything else: 10 works · 14.8% of their workLife Sciences: 4 works · 6.5% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 6.5% of their workMolecular Biology: 3 works · 3.8% of their workCancer Research: 2 works · 2.7% of their workTHEIR WORKClaas Wesseler66works
Life Sciences6%Health Sciences79%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine5278.7%
  2. Everything else1014.8%
    1. Biochemistry, Genetics and Molecular Biology46.5%
  1. 1Pulmonary and Respiratory Medicine40% of their works
  2. 2Oncology32% of their works
  3. 3Radiology, Nuclear Medicine and Imaging4% of their works
  4. 4Molecular Biology4% of their works
  5. 5Neurology3% of their works
  6. 6Cancer Research3% of their works

Research topics

Which keywords describe Claas Wesseler's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, ALK Inhibitors, EGFR Mutations, Chemotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1 and Genomic Profiles.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy633 topics
  2. Clinical Trials582 topics
  3. ALK Inhibitors401 topic
  4. EGFR Mutations401 topic
  5. Chemotherapy383 topics
  6. Immune Checkpoint Blockade191 topic
  7. PD-1 and PD-L1191 topic
  8. Genomic Profiles181 topic
  9. Small-Cell Lung Cancer181 topic
  10. CT Screening141 topic
  11. Lung Cancer141 topic
  12. Cetuximab61 topic
  13. KRAS Mutations61 topic
  14. Cancer Genomics51 topic
  15. Mutational Signatures51 topic
  16. Empyema41 topic
  17. Pleural Effusion41 topic
  18. Signaling41 topic
  19. mTOR41 topic

Where does Claas Wesseler work?

Claas Wesseler's main affiliation in the publication record is Asklepios Klinikum Harburg, Germany.

How many publications and citations does Claas Wesseler have?

OpenAlex counts 66 works and 800 citations for Claas Wesseler, an h-index of 13, ranking #2,346,224 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Claas Wesseler. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.